LPL Financial
NBRV

LPL Financial’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

LPL Financial’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$5K – 3915
2020
Q3 		$5K Hold
40
– – ﹤0.01% 3542
2020
Q2 		$7K Hold
40
– – ﹤0.01% 3450
2020
Q1 		$6K Hold
40
– – ﹤0.01% 3192
2019
Q4 		$13K Hold
40
– – ﹤0.01% 3328
2019
Q3 		$20K Hold
40
– – ﹤0.01% 3257
2019
Q2 		$24K Buy
+40
New +$24.5K ﹤0.01% 3241

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

LPL Financial's NBRV Position: Q4 2020 in Review

LPL Financial sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 40 shares — an estimated $5K sold.

LPL Financial first reported a position in NBRV in Q2 2019 and held it in 6 quarters. The position peaked at $24K in Q2 2019. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

  • LPL Financial reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
  • LPL Financial sold 40 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $5K.
  • LPL Financial first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2019 and held it in 6 quarters.
  • LPL Financial's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $24K in Q2 2019.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on LPL Financial's 13F filing for Q4 2020, filed 12 Feb 2021.